Compare OCGN & ORN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OCGN | ORN |
|---|---|---|
| Founded | 2013 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Military/Government/Technical |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 387.3M | 415.4M |
| IPO Year | N/A | 2007 |
| Metric | OCGN | ORN |
|---|---|---|
| Price | $1.60 | $12.04 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | $7.00 | ★ $13.75 |
| AVG Volume (30 Days) | ★ 6.2M | 255.9K |
| Earning Date | 03-04-2026 | 03-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.24 |
| Revenue | $5,370,000.00 | ★ $835,917,000.00 |
| Revenue This Year | $35.88 | $6.40 |
| Revenue Next Year | N/A | $3.28 |
| P/E Ratio | ★ N/A | $50.76 |
| Revenue Growth | ★ 14.26 | 7.02 |
| 52 Week Low | $0.52 | $4.64 |
| 52 Week High | $1.96 | $13.17 |
| Indicator | OCGN | ORN |
|---|---|---|
| Relative Strength Index (RSI) | 51.41 | 64.90 |
| Support Level | $1.57 | $10.58 |
| Resistance Level | $1.70 | $13.17 |
| Average True Range (ATR) | 0.14 | 0.52 |
| MACD | -0.02 | 0.17 |
| Stochastic Oscillator | 22.45 | 68.66 |
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").
Orion Group Holdings Inc is a specialty construction company serving the infrastructure, industrial, and building sectors, providing services both on and off the water in the continental United States, Alaska, Canada and the Caribbean Basin through its marine segment and its concrete segment. Its marine segment provides construction and dredging services relating to marine transportation facility construction, marine pipeline construction, marine environmental structures, dredging of waterways, channels and ports, environmental dredging, design, and specialty services. Its concrete segment provides turnkey concrete construction services including pour and finish, dirt work, layout, forming, rebar and mesh across the light commercial, structural and other associated business areas.